Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.10
Bid: 40.72
Ask: 40.80
Change: -0.24 (-0.58%)
Spread: 0.08 (0.196%)
Open: 41.36
High: 41.40
Low: 40.40
Prev. Close: 41.34
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

19 Jul 2016 07:00

RNS Number : 4948E
Assura PLC
19 July 2016
 

19 July 2016

 

Assura plc

 

Trading Update

For the first quarter to 30 June 2016

 

Continued strong growth

 

Assura plc ("Assura"), the UK's leading primary care property investor and developer, today publishes a trading update for the first quarter to 30 June 2016.

 

Value enhancing investment activity

 

Assura continued to make good progress in the first quarter, completing the acquisition of 30 medical centres for a gross consideration of £65.4 million with a passing rent roll of £4.1 million and a weighted average unexpired lease length of 14.1 years.

 

Assura has a further pipeline of individual asset acquisitions and developments currently in solicitors' hands worth £105 million.

 

Rental income increased

 

Assura now owns 351 medical centres with a total annualised rent roll of £68.4 million (31 March 2016: £63.8 million), with growth in the financial year to date driven primarily by acquisitions. In addition, we are maximising income through active asset management: the letting of vacant space has been a particular focus in the first quarter with £0.3 million in new lettings secured in the period.

 

The weighted average annual rent increase was 1.43% on the basis of 32 reviews settled in the quarter, of which open market rents reviews were 1.30%.

 

Strong financing and debt position

 

On 18 May 2016 we secured a new £200 million revolving credit facility on an unsecured basis to replace the existing facility. The initial margin is 150 basis points, which is a reduction of 20 basis points from the previous facility, and the facility increases operational flexibility and reduces transaction costs associated with financing properties. Undrawn facilities currently stand in excess of £115 million.

 

At 30 June 2016, Assura's loans stood at £411.9m, with a weighted average cost of debt of 4.55% (31 March 2016: 4.84%) and a weighted average debt maturity of 10.2 years. At the same date, Assura's proforma net loan to value ratio was 33% (31 March 2016: 30%).

 

Market background

 

We have seen no direct impact to date from the recent EU referendum, although we realise that the result may create political and economic uncertainty, which could affect investment in primary care infrastructure. However, the need for investment in primary care premises is recognised by the NHS as a priority, as more services are being provided by the primary care sector and there is also an increasing need to meet the health needs of a growing and ageing population.

 

 

Simon Laffin, Executive Chairman, commented:

 

"We have had another active quarter as we continue our strong growth. Our greater financial flexibility positions us well, while our investment strategy is continuing to generate value. Assura is increasingly well positioned to help the NHS develop the modern and effective primary care infrastructure that is so necessary for this country."

 

- Ends -

 

For more information, please contact:

 

Assura plc

 

Tel: 01925 420660

Simon Laffin

Jonathan Murphy

 

 

Finsbury

 

Tel: 0207 251 3801

Gordon Simpson

 

 

Notes to Editors

Assura plc, a constituent of the FTSE 250, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 31 March 2016, Assura's property portfolio was valued at £1,111 million.

 

Further information is available at www.assuraplc.com

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFVSDEITLIR
Date   Source Headline
11th Sep 20123:46 pmRNSResult of AGM
31st Aug 20123:56 pmRNSAnnual Information Update
15th Aug 20127:00 amRNSInterim Management Statement
16th Jul 20124:02 pmRNSChange of Registered Office
13th Jul 201211:16 amRNSDirector/PDMR Shareholding
2nd Jul 20124:12 pmRNSDirector/PDMR Shareholding
26th Jun 20127:00 amRNSPreliminary results for year ended 31 March 2012
30th May 20123:14 pmRNSAppointment of Joint Corporate Broker
23rd May 20122:57 pmRNSDirectorate Change
8th May 20127:00 amRNSDirectorate Change
29th Mar 20127:00 amRNSPre-close statement and Directorate Change
16th Mar 20124:38 pmRNSDirector Declaration
28th Feb 201211:10 amRNSHolding(s) in Company
27th Feb 20129:30 amRNSDirector/PDMR Shareholding
21st Feb 20129:58 amRNSDirector/PDMR Shareholding
13th Feb 20121:33 pmRNSAppointment of Auditors
9th Feb 20127:00 amRNSInterim Management Statement
30th Jan 201212:08 pmRNSDirector/PDMR Shareholding
26th Jan 20127:00 amRNSDirectorate Change
23rd Jan 20123:01 pmRNSDirector/PDMR Shareholding
4th Jan 20123:32 pmRNSDirector / PDMR Shareholding & Total Voting Rights
3rd Jan 20127:00 amRNSDirectorate Change
30th Dec 201112:10 pmRNSHolding(s) in Company
29th Dec 20114:35 pmRNSHolding(s) in Company
28th Dec 20117:00 amRNSHolding(s) in Company
28th Dec 20117:00 amRNSHolding(s) in Company
21st Dec 20113:58 pmRNSResult of Rump Placement
21st Dec 20112:18 pmRNSResult of Rights Issue
16th Dec 201112:32 pmRNSDirector/PDMR Shareholding
9th Dec 20118:16 amRNSDirector/PDMR Shareholding
6th Dec 20119:31 amRNSFurther re Rights Issue
2nd Dec 20111:50 pmRNSPublication of Prospectus
25th Nov 20111:20 pmRNSIssue of Debt
23rd Nov 20117:00 amRNSHalf Yearly Report
23rd Nov 20117:00 amRNSIssue of Equity
13th Oct 20117:00 amRNSHolding(s) in Company
8th Sep 20116:08 pmRNSAGM Statement
1st Sep 20117:00 amRNSAGM - Withdrawal of Resolution
15th Aug 20117:00 amRNSInterim Management Statement
8th Aug 201112:01 pmRNSAnnual Information Update
8th Aug 201110:38 amRNSDirectorate Change
2nd Aug 201112:53 pmRNSDirector/PDMR Shareholding
29th Jul 20114:26 pmRNSAnnual Financial Report
13th Jul 20113:05 pmRNSAdmission of ordinary shares
13th Jul 201111:13 amRNSDisposal of Pharmacy Division
21st Jun 20117:00 amRNSFinal Results
21st Jun 20117:00 amRNSSale of pharmacy division for £39.3m
15th Jun 20119:25 amRNSHolding(s) in Company
17th May 20117:00 amRNSHolding(s) in Company
13th May 20114:03 pmRNSRe Acquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.